ESHAP regimen

Revision as of 15:14, 16 March 2015 by Aparna Vuppala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for ESHAP regimen

Articles

Most recent articles on ESHAP regimen

Most cited articles on ESHAP regimen

Review articles on ESHAP regimen

Articles on ESHAP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ESHAP regimen

Images of ESHAP regimen

Photos of ESHAP regimen

Podcasts & MP3s on ESHAP regimen

Videos on ESHAP regimen

Evidence Based Medicine

Cochrane Collaboration on ESHAP regimen

Bandolier on ESHAP regimen

TRIP on ESHAP regimen

Clinical Trials

Ongoing Trials on ESHAP regimen at Clinical Trials.gov

Trial results on ESHAP regimen

Clinical Trials on ESHAP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ESHAP regimen

NICE Guidance on ESHAP regimen

NHS PRODIGY Guidance

FDA on ESHAP regimen

CDC on ESHAP regimen

Books

Books on ESHAP regimen

News

ESHAP regimen in the news

Be alerted to news on ESHAP regimen

News trends on ESHAP regimen

Commentary

Blogs on ESHAP regimen

Definitions

Definitions of ESHAP regimen

Patient Resources / Community

Patient resources on ESHAP regimen

Discussion groups on ESHAP regimen

Patient Handouts on ESHAP regimen

Directions to Hospitals Treating ESHAP regimen

Risk calculators and risk factors for ESHAP regimen

Healthcare Provider Resources

Symptoms of ESHAP regimen

Causes & Risk Factors for ESHAP regimen

Diagnostic studies for ESHAP regimen

Treatment of ESHAP regimen

Continuing Medical Education (CME)

CME Programs on ESHAP regimen

International

ESHAP regimen en Espanol

ESHAP regimen en Francais

Business

ESHAP regimen in the Marketplace

Patents on ESHAP regimen

Experimental / Informatics

List of terms related to ESHAP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:ESHAP Regimen; Etoposide-Solumedrol-High Dose Ara-C, Platinol Regimen

Overview

ESHAP regimen refers to a regimen consisting of etoposide, methylprednisolone (Solumedrol), high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and Non-Hodgkin's lymphoma[1][2] and rituximab added for the treatment of Diffuse large B-cell lymphoma. [3]

Regimen

EEtoposide

SMethylprednisolone (Solumedrol)

HHigh-dose

ACytarabine (Ara-c)

PCisplatin (Platinol)

Indications

References

  1. 1.0 1.1 Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA; et al. (1994). "ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study". J Clin Oncol. 12 (6): 1169–76. PMID 8201379.
  2. "NCI Thesaurus".
  3. Montoro J, Andreola G, Gardellini A, Babic A, Negri M, Frungillo N; et al. (2014). "R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma". Transfus Apher Sci. 50 (3): 411–4. doi:10.1016/j.transci.2014.03.006. PMID 24751603.
  4. "NCI Thesaurus".